ada guidelines glp-1 Comparison of the diabetes from the ADA/EASD and the AACE/ACE 🚨 Diabetes Guidelines Update 2026

Clinical trials showed tirzepatide is even more effective than semaglutide leading to an impressive loss of up to 20% of body weight in overweight or obese participants who took the drug for 72 weeks

It can be a powerful tool, but long-term success depends on medical oversight, nutrition, muscle preservation, realistic expectations, and follow-up care

10.1007/s001250051238 14 ButlerA

Daily dose: 25 units per day on a 1 ml insulin syringe

The conservative approach: at any dose escalation, implement the step-up protocol proactively (add Miralax the same week you increase dose) rather than waiting for symptoms to become severe